ロード中...
Evaluation of the fusion partner cell line SPYMEG for obtaining human monoclonal antibodies against influenza B virus
Influenza B virus has been known to infect humans and other animals, including seals. Vaccination efficacy varies across seasons. Human monoclonal antibodies (mAbs) can be useful for developing novel vaccines, guided by epitope analysis, and can be used therapeutically. Hybridoma technology has been...
保存先:
| 出版年: | J Vet Med Sci |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Japanese Society of Veterinary Science
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6021880/ https://ncbi.nlm.nih.gov/pubmed/29669959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1292/jvms.18-0146 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|